| Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, updates its shareholders on the clinical progress and corporate developments the company achieved during 2011. The company also provides insight on its accomplishments and plans for the first part of 2012. Dear Shareholders: We appreciate the continued support of our shareholders as Provectus continues to advance our goal of regulatory approval of our nove...continued PVCT pharmaceuticals pharmaceutical cancer |
Tuesday, April 24, 2012
Provectus Updates Shareholders in Its Annual CEO Letter
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment